|
⚲
|
| Keyboard |
| Catalio Capital Management LP
✚
|
|
|---|---|
| CRD # | 310374 |
| SEC # | 801-121976 |
| CIK # | 0001958125 |
| AUM | 2,176.6 M (2026-03-31) |
| Employees | 30 (43% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 410-989-6168 |
| Address | 512 W 22nd Street New York, NY 10011 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5: Fees and Compensation Catalio provides investment advisory services to the Clients and is compensated for these services. Each Client’s Governing Documents set forth in detail the fee structure relevant to each such Client as well as the expenses to be borne in connection with such engagement. All Investors, counterparties and, in the case of the Funds, prospective investors, in a Fund should review the Governing Documents of each Fund in which they have invested or intend to invest for complete information on the fees, compensation and expenses applicable to a particular Fund. A brief summary of the Funds’ fees, compensation and expenses, as well as the general fee structure for the SMAs and Sub-Advisory Clients is provided below. Management Fee Catalio is paid an investment management fee (the “Management Fee”) by each Client as further described in the respective Client’s Governing Documents. Management Fees for the Funds typically range from 1% to 2% (per annum). The Management Fee typically is paid to Catalio quarterly (and pro-rated for any partial periods) and paid directly from the applicable Client’s assets, current income and disposition proceeds received, and, to the extent necessary, from drawdowns. Catalio, in its sole discretion, may waive or modify the Management Fee for any Investor. In the past, Catalio has waived the Management Fee for employees, venture partners, strategic partners, and certain investors, advisors and consultants, and expects to continue to do so in the future. Management Fees for Sub-Advisory Clients and SMAs are further described in the respective Governing Documents. Management Fees for the Sub-Advisory Clients or SMAs may be scaled based on the AUM being managed in the applicable relationship. Any new Fund launched by Catalio, or a new Sub-Advisory Client or SMA, may have materially different terms related to Management Fees than those summarized above. Client Expenses In addition to the Management Fees and any incentive-based compensation (as described in Item 6 below), the Clients pay (or reimburse Catalio for bearing) certain fees and expenses as set forth in more detail in each Client’s Governing Documents. The fees and expenses may differ by Client. For the Funds, fees and expenses typically include each Fund’s organizational and ongoing operating costs and expenses. For example, each Fund typically bears all expenses incurred in the diligencing, structuring, holding, purchase, sale, hedge or exchange of investments (whether or not ultimately consummated), including, but not by way of limitation, private placement fees, finder’s fees, interest on borrowed money, real property or personal property taxes on investments, including documentary, recording, stamp and transfer taxes, brokerage fees or commissions (including any merger fees), professional fees, travel expenses, legal fees, expenses incurred in connection with the investigation, prosecution or defense of any claims by or against such Fund, including claims by or against a governmental authority, audit and accounting fees, legal, accounting and consulting fees relating to investments or proposed investments, taxes applicable to such Fund on account of its operations, fees incurred in connection with the maintenance of bank or custodian accounts including expenses attributable to normal and extraordinary investment banking, commercial banking, appraisal, custodial, transfer and registration services provided to such Fund, fees or government charges which may be assessed against such Fund, all expenses incurred in connection with the registration of such Fund’s securities under applicable securities laws or regulations and ongoing compliance with such laws or regulations, costs associated with complying with marketing and/or offering rules of any jurisdictions, as well as costs of all governmental returns, reports and filings, governmental registration, filing and licensing costs and fees relating to such Fund, the applicable Advisory Affiliate and Catalio, and travel expenses incurred in managing and holding Fund investments. Each Fund also bears expenses incurred by an applicable Advisory Affiliate in diligencing and evaluating investment opportunities whether or not consummated (including but not limited to legal, accounting and consulting fees, and travel expenses incurred in connection therewith), managing investments of such Fund, serving as the partnership representative for tax purposes, the reasonable cost of liability and other premiums for insurance protecting such Fund, the applicable Advisory Affiliate, and Catalio and its employees from liability to third parties, all expenses in connection with preparing and distributing reports to prospects and Investors, expenses in connection with Fund communications with prospects and Investors, including preparation of annual or other reports to the Investors, costs associated with Fund meetings or conferences with prospects and Investors, costs associated with limited partner advisory committee meetings, all legal and accounting fees relating to such Fund and its activities, fees and expenses relating to finance, reporting, administration, accounting and back-office services, whether outsourced or provided by Catalio, expenses incurred in connection with research and quotation technology, databases and subscriptions, all costs and expenses arising out of the such Fund’s indemnification obligations, and all expenses that are not normal operating expenses as set forth in the applicable Governing Documents. In general, each Investor will bear its proportionate share of a Fund’s expenses pro rata based on the size of such Investor’s investment in the Fund. Notwithstanding the foregoing, Catalio may specially allocate a Fund’s expenses in any other manner, including by allocating certain expenses to certain (but not all) Investors, if Catalio reasonably determines, in its discretion, that it is more ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7: Types of Clients As described in Item 4 above, our clients are the Funds, Sub-Advisory Clients, and SMAs. The Funds are generally open to, among others, institutions, pension plans, endowments, high net-worth individuals, financially sophisticated individuals, and other qualified investors. Our Sub-Advisory Clients are currently other asset managers that are seeking exposure to the biomedical technology sectors and are relying on Catalio’s experience investing in the area. Our SMAs are currently with institutions that are provided the opportunity to invest pari passu with the applicable Funds, subject to certain specific investment parameters. As noted above, in certain circumstances, we may consider advising SMAs or Sub-Advisory Clients for certain investors, which may receive different information rights including portfolio transparency and may have different fee and/or liquidity rights than those granted to Investors in the Funds. The determination or willingness to enter into a SMA may be subject to minimum asset levels determined by Catalio in its sole discretion. |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Magenta Therapeutics Inc | 47.0 | ||
| Bridgebio Pharma Inc | 32.1 | ||
| Ascendis Pharma A/S | 29.5 | ||
| Bristol Myers Squibb Co | 25.5 | ||
| Syndax Pharmaceuticals Inc | 24.4 | ||
| Gilead Sciences Inc | 22.8 | ||
| MIND Medicine Mindmed Inc | 19.6 | ||
| Boston Scientific Corp | 18.8 | ||
| Ultragenyx Pharmaceutical Inc | 17.8 | ||
| Incyte Corp | 17.1 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Catalio Genesis Fund IX LLC | [2026-03-31] | 8.6 M | 10.0 M |
| Offered $8,625,000 · Filed 2025-07-03 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund VIII LLC | [2026-03-31] | 15.2 M | 14.5 M |
| Offered $15,247,500 · Filed 2025-04-16 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund VI LLC | [2026-03-31] | 15.5 M | 14.8 M |
| Offered $15,497,500 · Filed 2025-04-16 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| Other | Catalio Inflection Fund I LLC | [2026-03-31] | 12.5 M | 12.9 M |
| Offered $12,500,000 · Filed 2025-04-10 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $50,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Access Fund VII LLC | [2025-03-28] | 5.0 M | 5.7 M |
| Offered $5,000,000 · Filed 2024-06-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund V LLC | [2025-03-28] | 11.5 M | 12.1 M |
| Offered $11,480,000 · Filed 2024-05-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| Other | Catalio Structured Opportunities Fund II LP | [2025-03-28] | 63.5 M | 143.5 M |
| Filed 2025-01-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,480,000 · Revenue Decline to Disclose | ||||
| Other | Catalio Structured Opportunities Offshore Fund II LP | [2025-03-28] | 36.9 M | 81.3 M |
| Filed 2025-01-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Commission $1,480,000 · Revenue Decline to Disclose | ||||
| PE | Catalio Nexus Fund IV LP | [2024-03-26] | 357.6 M | 348.9 M |
| Filed 2026-01-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Catalio Public Equities Master Fund LP | [2024-03-26] | 142.1 M | 161.6 M |
| Filed 2026-02-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 0.2 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 26 | 1.4 |
| (g) Pension and profit sharing plans | 1 | 0.0 |
| (h) Charitable organizations | 1 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 2 | 0.2 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 1 | 0.0 |
| (n) Other | 1 | 0.2 |
| Total | 33 | 2.2 |
| By Discretionary | ||
| Discretionary | 31 | 1.9 |
| Non-Discretionary | 2 | 0.2 |
| Total | 33 | 2.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.7 | |
| United States Persons | 1.5 | |
| Total | 33 | 2.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Abali Hoilett | Director | 137 | 35 | |
| Peter Huber | Director | 88 | 22 | |
| Kim Bishop | Director | 50 | 17 | |
| Christine Clarke | Executive Officer | 56 | 5 | |
| Arthur Cohen | Executive Officer | 57 | 4 | |
| Joseph Healey | Executive Officer | 54 | 4 | |
| LP HealthCor Management | Executive Officer | 46 | 3 | |
| David Warnock | Director | 33 | 3 | |
| Joseph Sherman | Director | 21 | 3 | |
| R Vogelstein | Director, Executive Officer | 17 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001958125] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300P3CYP9WVN0M608 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Varadero Capital LP
✚
|
NY | 2,292.2 M |
|
Waratah Capital Advisors Ltd
✚
|
2,271.0 M | |
|
Coliseum Capital Management LLC
✚
|
CT | 2,269.4 M |
|
Teng Yue Partners LP
✚
|
NY | 2,247.5 M |
|
Mason Capital Management LLC
✚
|
NY | 2,237.5 M |
|
FEG Investment Services LLC
✚
|
OH | 2,230.7 M |
|
LUPA RIA Investment Management LLC
✚
|
NY | 2,189.3 M |
|
RP Management LLC
✚
|
NY | 2,139.0 M |
|
Albion River Management LLC
✚
|
MD | 2,062.2 M |
|
Flat Footed LLC
✚
|
WY | 2,059.5 M |